HK Close | HSI and HSTECH Edge Up; Biocytogen Up 22%; Qingsong Health Up 14%; Dobot Up 9%; SMIC Up 3%

I. Market Overview

The Hong Kong market posted modest gains on Dec 24, with benchmarks closing near their intraday ranges. The Hang Seng Index (HSI) rose 0.17% to 25,818.93, the Hang Seng China Enterprises Index (HSCEI) added 0.01% to 8,915.12, and the Hang Seng Tech Index (HSTECH) advanced 0.19% to 5,499.30. Trading reflected holiday-thinned participation and a defensive tone, with semiconductors and select materials names outperforming while some healthcare and consumer pockets lagged.

Total market turnover was HKD 92.52 billion, signaling lighter activity ahead of the year-end holiday period. Breadth improved in cyclical and asset-heavy segments (resources, REITs), whereas platform tech and healthcare were mixed to weaker.

II. Sector Performance

Large-cap Tech Stocks
Semiconductors outperformed within tech, with SMIC +3.12% to 71.05 and Hua Hong Semiconductor +1.64% to 71.45, while platforms were mixed (Tencent +0.17% to 603.00, Meituan 0.00% at 103.20, Alibaba -0.82% to 146.00); autos were steady (BYD Company +0.54% to 93.60, Xiaomi +0.05% to 39.22).

Top Performing Sectors
• Agricultural Products +6.11%
• Research & Consulting Services +4.50%
• Office REITs +3.61%

Bottom Performing Sectors
• Oil & Gas Refining & Marketing -5.52%
• Computer & Electronics Retail -2.13%
• Security & Alarm Services -2.05%

III. Top 10 Gainers in Hong Kong Market Today

USD 1B." title="Filter: Market cap > USD 1B." tg-width="467" tg-height="379"/>Filter: Market cap > USD 1B.

IV. Top 10 Losers in Hong Kong Market Today

USD 1B." title="Filter: Market cap > USD 1B." tg-width="449" tg-height="371"/>Filter: Market cap > USD 1B.

V. Closing Summary

The Hong Kong market traded in a narrow range and finished slightly higher on Dec 24. The HSI (+0.17%) and HSTECH (+0.19%) led modestly, with the HSCEI (+0.01%) essentially flat. Turnover at HKD 92.52 billion underscored quieter holiday conditions. Gains were supported by cyclical areas tied to commodities and property cash-flow assets, while parts of consumer and healthcare traded lower amid stock-specific moves.

Large-cap tech showed a mixed profile. Semiconductors were notably firm—SMIC (+3.12%) and Hua Hong (+1.64%)—reflecting steady demand expectations and ongoing sector rotation into upstream hardware. Platform names were more subdued, with Tencent (+0.17%) and Meituan (0.00%) holding steady and Alibaba (-0.82%) easing, while autos were broadly steady (BYD Company +0.54%, Xiaomi +0.05%). Select software and services names drifted lower, but the overall tech complex maintained a slightly positive bias.

Beyond tech, resources and industrials moved higher, consistent with sector prints: Agricultural Products and Research & Consulting Services outperformed, and Office REITs posted solid gains. Among individual movers, battery materials and robotics were strong, including CNGR (+9.09%), Global New Materials (+9.28%), LYGEND RESOURCE (+11.44%), and DOBOT (+9.41%). Dairy and mining exposure also gained (YOURAN DAIRY +7.34%, XINXIN MINING +7.42%). On the downside, a number of healthcare/biotech names and select consumer and battery peers fell, including ALPHAMAB-B (-7.30%), DUALITYBIO-B (-4.63%), TRANSTHERA-B (-5.79%), TANWAN (-5.35%), and CALB (-5.00%).

Sector moves were consistent with the macro tone: REITs and asset-heavy categories advanced, while Oil & Gas Refining & Marketing (-5.52%) lagged at the bottom of the table alongside Computer & Electronics Retail (-2.13%) and Security & Alarm Services (-2.05%). IPO-related activity and broader listing news were limited in today’s intraday window, and trading liquidity was light, suggesting positioning rather than trend reversals drove the session. Into year-end, market attention is likely to remain on semiconductors and selected materials, with platform tech taking a wait-and-see approach amid lighter flows.

Sources: Public market data, summarized media reports
Disclaimer: This content is for reference only and does not constitute investment advice.